Works matching IS 10600280 AND DT 2008 AND VI 42 AND IP 2
1
- 2008
- Kaushik P;
- Soule MR;
- Ellison WA;
- Ahmed B;
- Kaushik R
- Journal Article
2
- 2008
- André N;
- Milano E;
- Rome A;
- Gentet JC
- Journal Article
7
- 2008
- Sawyer E;
- Mauro LS;
- Ohlinger MJ
- Journal Article
8
- 2008
- Forrest GN;
- Donovan BJ;
- Lamp KC;
- Friedrich LV
- Journal Article
9
- 2008
- van Geffen ECG;
- van Hulten R;
- Bouvy ML;
- Egberts ACG;
- Heerdink ER
- Journal Article
10
- 2008
- Berg ML;
- Crank CW;
- Philbrick AH;
- Hayden MK
- Journal Article
11
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 293, doi. 10.1345/aph.1K483
- Article
12
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 292
- Article
13
- 2008
- Sansgiry SS;
- Chien C;
- Jayawant SS;
- Raju A
- Journal Article
14
- 2008
- Khanderia U;
- Townsend KA;
- Erickson SR;
- Vlasnik J;
- Prager RL;
- Eagle KA
- Journal Article
15
- 2008
- Weycker D;
- Edelsberg J;
- Vincze G;
- Levy DG;
- Kartashov A;
- Oster G
- Journal Article
16
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 294, doi. 10.1345/aph.1BR08B
- Article
17
- 2008
- Chen Y;
- Guo JJ;
- Li H;
- Wulsin L;
- Patel NC
- Journal Article
18
- 2008
- Cat TB;
- charash W;
- Hebert J;
- Marden BT;
- Corbett SM;
- Ahern J;
- Rebuck JA
- Journal Article
19
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 292, doi. 10.1345/aph.1K331
- Article
20
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 291, doi. 10.1345/aph.1K162bc
- Article
21
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 290, doi. 10.1345/aph.1K524
- Article
22
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 289, doi. 10.1345/aph.1K548
- Article
23
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 288, doi. 10.1345/aph.1K511
- Article
24
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 284, doi. 10.1345/aph.1K576
- Article
25
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 278, doi. 10.1345/aph.1K514
- Article
26
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 273, doi. 10.1345/aph.1K616
- Article
27
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 270, doi. 10.1345/aph.1K523
- Article
28
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 265, doi. 10.1345/aph.1K469
- Article
29
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 259, doi. 10.1345/aph.1K303
- Article
30
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 253, doi. 10.1345/aph.1K590
- Article
31
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 247, doi. 10.1345/aph.1K284
- Article
32
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 237, doi. 10.1345/aph.1K445
- Article
33
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 226, doi. 10.1345/aph.1K086
- Article
34
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 218, doi. 10.1345/aph.1K516
- Article
35
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 213, doi. 10.1345/aph.1K535
- Article
36
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 207, doi. 10.1345/aph.1K365
- Article
37
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 200, doi. 10.1345/aph.1K092
- Article
38
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 192, doi. 10.1345/aph.1K497
- Article
39
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 185, doi. 10.1345/aph.1K328
- Article
40
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 177, doi. 10.1345/aph.1K369
- Article
41
- Annals of Pharmacotherapy, 2008, v. 42, n. 2, p. 169, doi. 10.1345/aph.1K506
- Article